SCHEMBL13008342

SCHEMBL13008342

CC1(C)c2ccccc2-c2ccc(-c3cccc(-c4c5ccc(N6c7ccccc7C(C)(C)c7ccccc76)cc5c(-c5cccc(-c6ccc7c(c6)C(C)(C)c6ccccc6-7)c5)c5ccc(N6c7ccccc7C(C)(C)c7ccccc76)cc45)c3)cc21

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 10/20 0.36
PGR P06401 9/20 0.34
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13427498 1.00 PDK2 (0.36) PDK2PGRMEN1KMT2A
SCHEMBL13008724 0.98 PDK2 (0.35) PDK2PGR
SCHEMBL13008876 0.95 PGR (0.34) PDK2PGRMEN1KMT2A
SCHEMBL13009086 0.95 PGR (0.34) PDK2PGRMEN1KMT2A
SCHEMBL13008861 0.94 PGR (0.33) PDK2PGRMEN1KMT2A
SCHEMBL13009460 0.94 PGR (0.33) PDK2PGRMEN1KMT2A
SCHEMBL13009458 0.94 PDK2 (0.33) PDK2PGRMEN1KMT2A
SCHEMBL13427431 0.94 PDK2 (0.33) PDK2PGRMEN1KMT2A
SCHEMBL13427660 0.93 PDK2 (0.33) PDK2PGR
SCHEMBL13009288 0.93 PDK2 (0.33) PDK2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A PDK2 3608/4885PGR 2458/4885MEN1 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.